Yeah, we know the so called big brother is hurting, in fact very...

Yeah, we know the so called big brother is hurting, in fact very bad, but reason it out.

- they have over promised and under prepared, under executed, under educated, under marketed, under delivered

- they now have increased competition, stiff competition in the Prostate cancer space, from Medivation who just announced excellent results. Such strong results that they have stopped their trials and are going to give those men on the placebo the actual drug.

http://www.thestreet.com/_yahoo/story/11298696/1/medivation-scores-big-prostate-cancer-drug-victory.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA

- Dendreon are an extremely US centric company

- Dendreon have nothing else

Now look at Prima:

- Cvac (very promising) with multiple cancers treatment potential

- 'soon' to list on the Nasdaq

- Dubai sales outside of trials about to commence

- Ovarian cancer market with unmet need

- orphan drug status

- oral HPV

- aspherisis treatment service

- likelihood to go to market in many countries

- NO threatening competition. Prima is at the front of the queue for the immunotherapy vaccine Ov cancer treatment market

- tried and tested, proven technology

- highly highly under valued


All of the above are no reason why Prima is dead, but every reason Prima is alive and kicking. They just need to continue to observe, learn lessons from others' mistakes and be clever bunnies.

Good luck holders and welcome new holders, especially soon to be former Dendreonites!!

Prima needs YOUR support - now - please show it.